Immunodiagnosis — the promise of personalized immunotherapy

Immunotherapy showed remarkable efficacy in several cancer types. However, the majority of patients do not benefit from immunotherapy. Evaluating tumor heterogeneity and immune status before treatment is key to identifying patients that are more likely to respond to immunotherapy. Demographic charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Renjie, Xiong, Kairong, Wang, Zhimin, Wu, Di, Hu, Bai, Ruan, Jinghan, Sun, Chaoyang, Ma, Ding, Li, Li, Liao, Shujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372420/
https://www.ncbi.nlm.nih.gov/pubmed/37520576
http://dx.doi.org/10.3389/fimmu.2023.1216901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372420/
https://www.ncbi.nlm.nih.gov/pubmed/37520576
http://dx.doi.org/10.3389/fimmu.2023.1216901

Ejemplares similares